Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

C. R. Bard Inc. buy dimontalban

Start price
€120.65
24.11.14 / 50%
Target price
€180.40
30.04.15
Performance (%)
10.79%
End price
€133.27
30.04.15
Summary
This prediction ended on 30.04.15 with a price of €133.27. The prediction had a final performance of 10.79%. dimontalban has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
C. R. Bard Inc. - - - -
iShares Core DAX® -0.315% -2.776% 12.361% 15.821%
iShares Nasdaq 100 1.250% 7.480% 34.131% 57.547%
iShares Nikkei 225® -1.284% -2.199% 5.146% 3.302%
iShares S&P 500 1.141% 4.717% 28.724% 51.350%

Comments by dimontalban for this prediction

In the thread C. R. Bard Inc. diskutieren
Prediction Buy
Perf. (%) 10.79%
Target price 180.400
Change
Ends at 30.04.15

Monezin

Der Spezialist für medizinisches Equipment ist seit Jahren im Aufwind und einen soliden Trend sollte man nicht verpassen.

Prediction Buy
Perf. (%) 10.79%
Target price 180.400
Change
Ends at 30.04.15

(Stop Loss Kurs erreicht)